| Title: |
Garadacimab for hereditary angioedema prophylaxis: Long-term efficacy and safety from the VANGUARD Phase 3b open-label extension trial (first interim analysis) |
| Authors: |
Resehf, A; Margerl, M; Martinez-Saguer, I; Bernstein, JA; Farkas, H; Yang, WH; Jacobs, JS; Li, PH; Lumry, WR; Aygoren-Pursun, E; Ohsawa, I; Kateralis, C; Longhurst, H; Hakl, R; Guilarte, M; Stroes, ESG; Chen, YH; Feuersenger, H; Bica, A; Jacobs, I; Craig, TJ |
| Publication Year: |
2023 |
| Collection: |
University of Hong Kong: HKU Scholars Hub |
| Document Type: |
conference object |
| Language: |
English |
| Relation: |
13th C1-inhibitor Deficiency & Angioedema Workshop; 344521; https://hub.hku.hk/handle/10722/326528 |
| Availability: |
https://hub.hku.hk/handle/10722/326528 |
| Accession Number: |
edsbas.6DFB9B22 |
| Database: |
BASE |